Compare SYRE & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYRE | NPO |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | 112 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.6B |
| IPO Year | 2015 | 2002 |
| Metric | SYRE | NPO |
|---|---|---|
| Price | $73.58 | $308.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $85.08 | ★ $278.33 |
| AVG Volume (30 Days) | ★ 927.8K | 226.1K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.46% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $1,532,000,000.00 |
| Revenue This Year | N/A | $12.31 |
| Revenue Next Year | N/A | $6.39 |
| P/E Ratio | ★ N/A | $234.30 |
| Revenue Growth | N/A | ★ 16.98 |
| 52 Week Low | $13.93 | $177.34 |
| 52 Week High | $78.80 | $326.98 |
| Indicator | SYRE | NPO |
|---|---|---|
| Relative Strength Index (RSI) | 57.09 | 57.37 |
| Support Level | $67.18 | $211.15 |
| Resistance Level | $76.16 | $326.98 |
| Average True Range (ATR) | 4.12 | 12.44 |
| MACD | -0.97 | -1.64 |
| Stochastic Oscillator | 62.77 | 66.59 |
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.